Physician

Gauhar R Khan, M.D.

According to 2025 Medicare claims, Gauhar Khan, M.D. (NPI: 1922162114) practices cardiology in the Modesto, CA market, with the plurality of this provider's patient population coming from Stanislaus, CA. This provider's primary affiliated billing organization is SUTTER VALLEY MEDICAL FOUNDATION (NPI: 1669846986; TIN: 680273974) and primary practice location at 95355-2707. Khan is affiliated with the Sutter Medicare Direct (ACO ID: A5279), participating under the MSSP model.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,966 traditional Medicare patients, billed 7,457 HCPCS/CPT codes, and received $526,802 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 5,447 prescription claims across 854 beneficiaries totaling $828,696 in drug costs, led by Eliquis (Apixaban). 2019 DME data shows 11 claims. Open Payments data shows 18 records totaling $2,255. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $239,032 to $526,802. Similarly, Part D prescription costs have moved sharply higher in recent years, from $162,363 to $828,696. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	977	3,487	$239,032
2016	1,000	3,694	$262,436
2017	1,007	3,621	$266,449
2018	1,138	3,901	$300,041
2019	1,428	4,157	$342,735
2020	1,366	5,033	$476,105
2021	1,510	5,441	$490,464
2022	1,901	6,332	$496,037
2023	1,876	6,037	$474,981
2024	1,966	7,457	$526,802

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	324	3,304	$162,363
2016	329	3,867	$223,321
2017	375	4,208	$225,663
2018	398	4,365	$277,163
2019	483	3,011	$251,135
2020	406	1,726	$215,803
2021	529	2,818	$217,251
2022	712	4,164	$382,544
2023	800	5,085	$738,830
2024	854	5,447	$828,696

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	11	$78
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	599	625	$118
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	719	1,222	$93
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	583	730	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	377	391	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	589	739	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	311	19,014	$369,512
Jardiance	Empagliflozin	92	5,786	$108,587
Farxiga	Dapagliflozin Propanediol	104	5,190	$93,543
Entresto	Sacubitril/Valsartan	48	2,677	$57,805
Xarelto	Rivaroxaban	43	2,550	$47,004

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$2,255	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gauhar R. Khan, M.D.?

Tedicare shows public-source Medicare data for Gauhar R. Khan, M.D. (NPI 1922162114), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gauhar R. Khan, M.D. have ACO affiliation data?

Gauhar R. Khan, M.D. is shown with ACO affiliation data for Sutter Medicare Direct (MSSP, ACO ID A5279).

What billing organization is linked to Gauhar R. Khan, M.D.?

Gauhar R. Khan, M.D. is linked to SUTTER VALLEY MEDICAL FOUNDATION (billing NPI 1669846986) in the available physician profile data.

Does Gauhar R. Khan, M.D. have Open Payments data?

Gauhar R. Khan, M.D. has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.